Ximedica Puts Roots Down in California with Latest Acquisition

Ximedica, a full-service medical technology development company, is heading west, having acquired San Francisco, Calif.-based Bridge Design Inc.

Bridge Design provides Providence, R.I.-based Ximedica with a West Coast hub and an expanded front-end offering of design services for physical and digital products, including mHealth. Bridge Design’s clients range from Fortune 500 to startups, including device manufacturers, pharmaceutical, and life science firms as well as companies in consumer health and wellness.

“This partnership has been formed to broaden the strength, reach and scale of Ximedica’s development offering,” said Randall S. Barko, Ximedica’s president and CEO. “Ximedica brings the regulated systems, procedures and expertise to complement Bridge Design’s two-plus decades of award-winning design in medtech. By combining these strengths, we bring high value to our clients, offering a cost-effective development approach and a depth of expertise aligned with industry trends for digitally connected solutions.”

Aidan Petrie, chief innovation officer and co-founder of Ximedica, added: “This is about two organizations that share the same innovative DNA locking arms and setting a new bar for the design and development of medical technologies.”

Bridge Design, a now a Ximedica Company, will continue operating out of its current San Francisco office, drawing on the back-end capabilities of Ximedica to expand offerings with existing clients while servicing new relationships with key customers on the West Coast.

“By joining forces with Ximedica,” said Bill Evans, president of Bridge Design, “we will be able to respond to an increasing demand from our client base for a more comprehensive offering. We believe this will resonate deeply as major growth areas like mHealth build strength. In addition, we are looking forward to scaling our team and talent and fueling a common hunger to solve substantive design problems with elegant and engaging solutions.”

Ximedica’s westward move ties into an ongoing expansion strategy started in the fall of 2014 when SV Life Sciences, a Boston, Mass.-based private-equity firm, purchased a majority stake in the firm.

“Ten months ago we partnered with SV Life Sciences and embarked on the next phase of our global growth strategy,” Barko noted. “The acquisition of Bridge Design moves us further down that path. Bringing together top design and integrated engineering is nothing short of a powerful synergy and we look forward to seeing the impact we can create ahead.”